These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 18393156

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML, Hess S, Mulders T, Lam MG.
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
    He YX, Guo QY.
    Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD.
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [Abstract] [Full Text] [Related]

  • 10. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
    Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM.
    AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
    [Abstract] [Full Text] [Related]

  • 11. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [Abstract] [Full Text] [Related]

  • 12. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H.
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [Abstract] [Full Text] [Related]

  • 13. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F.
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [Abstract] [Full Text] [Related]

  • 14. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.
    Oncology; 2007 May; 72 Suppl 1():104-10. PubMed ID: 18087190
    [Abstract] [Full Text] [Related]

  • 15. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY, Lee YN, Kim YS, Kim SG, Jin SJ, Park JM, Choi GS, Chung JC, Lee MH, Cho YH, Choi MH, Kim DC, Choi HJ, Moon JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS.
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [Abstract] [Full Text] [Related]

  • 16. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ, Delbeke D, Morris D, Rice M, Washington MK, Shyr Y, Pinson CW, Chapman WC.
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [Abstract] [Full Text] [Related]

  • 17. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 18. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla JF, Sainz-Esteban A, Barragán J, Portilla-Quattrociocchi H, Carril JM.
    Rev Esp Med Nucl; 2008 Jan 01; 27(3):168-75. PubMed ID: 18570858
    [Abstract] [Full Text] [Related]

  • 19. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS, Lee SM.
    Anticancer Res; 2014 May 01; 34(5):2551-4. PubMed ID: 24778075
    [Abstract] [Full Text] [Related]

  • 20. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.
    Liver Transpl; 2010 Jun 01; 16(6):767-72. PubMed ID: 20517911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.